Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saline Injections for Chronic Migraine
NCT03919045Phase 4Terminated
- Sponsor
- University of Gothenburg
- Start
- Jun 2019
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of sodium chloride in chronic migraine (2 arms), sponsored by University of Gothenburg. Primary endpoint: Change in number of Days with headache at 24 weeks. Started Jun 2019; status: terminated.
02
Drugs
sodium chloride
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT03919045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03919045.